News

Yahoo Finance16d
Aspire Biopharma provides development update on BUZZ BOMB supplement
Aspire Biopharma (ASBP) announced the brand name BUZZ BOMB and anticipated market launch for its novel sublingual pre-workout supplement. BUZZ BOMB features 50mg of caffeine and is designed to ...
Finanznachrichten17d
Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB, its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025
BUZZ BOMB features 50mg of caffeine and is designed to support sustained energy and mental focus, helping athletes and fitness enthusiasts maximize their performance potential. Aspire has ...
The Globe and Mail17d
Pharma Stock Massively Bid Up Following New Product Announcement
A Pharmaceuticals company based out of Puerto Rico is turning heads so far during Wednesday’s premarket hours after the company introduced its new “BUZZ BOMB” pre-workout supplement and ...
Nasdaq17d
Aspire Biopharma To Launch BUZZ BOMB Sublingual Pre-Workout; Begins Production And Testing
(RTTNews) - Aspire Biopharma Holdings, Inc. (ASBP), a clinical-stage biopharmaceutical company, on Wednesday announced that it has begun initial production of BUZZ BOMB, its new sublingual pre ...
Nasdaq17d
Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025
Global pre-workout supplements market size is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030 Aspire has commenced initial production of BUZZ BOMB™, its ...
Kansas City Star17d
Atlas Cloud Launches High-Efficiency AI Inference Platform, Outperforming DeepSeek
Developed with SGLang, Atlas Inference surpasses leading AI companies in throughput and cost, running DeepSeek V3 & R1 faster than DeepSeek themselves. NEW YORK CITY, NEW YORK / ACCESS Newswire ...